Big Pharma Split Corp Class A Market Cap ($14.75 Million)
Market Cap & Net Worth: Big Pharma Split Corp Class A (PRM)
Big Pharma Split Corp Class A market cap. Big Pharma Split Corp Class A (TO:PRM) has a market capitalization of $14.75 Million (CA$20.39 Million) as of November 5, 2026. Listed on the TO stock exchange, this Canada-based company holds position #25886 globally and #1020 in its home market, demonstrating a 3.46% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Big Pharma Split Corp Class A's stock price CA$15.53 by its total outstanding shares 1312838 (1.31 Million). Also see Big Pharma Split Corp Class A cash conversion from operations for how efficiently the company converts equity into cash flow.
Big Pharma Split Corp Class A Market Cap History (2017–2026)
Big Pharma Split Corp Class A market cap history from 2017 to 2026. Data shows growth from $6.86 Million to $14.75 Million (8.72% CAGR). Check PRM stock price for real-time trading data and today's change.
Big Pharma Split Corp Class A Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Big Pharma Split Corp Class A's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore PRM year-over-year net asset growth to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
9.09x
Big Pharma Split Corp Class A's market cap is 9.09 times its annual revenue
Latest Price to Earnings (P/E) Ratio
3.00x
Big Pharma Split Corp Class A's market cap is 3.00 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2017 | $6.86 Million | $407.11K | $323.22K | 16.86x | 21.23x |
| 2018 | $6.61 Million | $3.23 Million | $2.78 Million | 2.05x | 2.38x |
| 2019 | $8.28 Million | $2.43 Million | $5.83 Million | 3.40x | 1.42x |
| 2020 | $8.70 Million | $589.26K | $265.42K | 14.76x | 32.78x |
| 2021 | $10.93 Million | $5.36 Million | $4.85 Million | 2.04x | 2.25x |
| 2022 | $11.84 Million | $3.71 Million | $3.15 Million | 3.19x | 3.76x |
| 2023 | $12.17 Million | $311.76K | -$139.68K | 39.04x | N/A |
| 2024 | $12.36 Million | $1.85 Million | -$538.62K | 6.68x | N/A |
| 2025 | $13.21 Million | $1.45 Million | $4.40 Million | 9.09x | 3.00x |
Competitor Companies of PRM by Market Capitalization
Companies near Big Pharma Split Corp Class A in the global market cap rankings as of November 5, 2026. Also see how large is Big Pharma Split Corp Class A's balance sheet for a full breakdown of the balance sheet.
Key companies related to Big Pharma Split Corp Class A by market ranking:
- BlackRock Inc (NYSE:BLK): Ranked #133 globally with a market cap of $167.86 Billion USD.
- Brookfield Corporation (TO:BN): Ranked #281 globally with a market cap of $92.30 Billion USD ( CA$127.60 Billion CAD).
- Blackstone Group Inc (NYSE:BX): Ranked #299 globally with a market cap of $88.95 Billion USD.
- KKR & Co. Inc. (NYSE:KKR): Ranked #311 globally with a market cap of $86.16 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #133 | BlackRock Inc | NYSE:BLK | $167.86 Billion | $1161.32 |
| #281 | Brookfield Corporation | TO:BN | $92.30 Billion | CA$56.85 |
| #299 | Blackstone Group Inc | NYSE:BX | $88.95 Billion | $118.19 |
| #311 | KKR & Co. Inc. | NYSE:KKR | $86.16 Billion | $95.99 |
Market Capitalization of Big Pharma Split Corp Class A (2017–2026)
Market capitalization of Big Pharma Split Corp Class A from 2017 to today. Between 2017 and today, Big Pharma Split Corp Class A's market cap moved from $6.86 Million to $ 14.75 Million, with a yearly change of 8.72%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CA$14.75 Million | +11.65% |
| 2025 | CA$13.21 Million | +6.92% |
| 2024 | CA$12.36 Million | +1.51% |
| 2023 | CA$12.17 Million | +2.83% |
| 2022 | CA$11.84 Million | +8.32% |
| 2021 | CA$10.93 Million | +25.61% |
| 2020 | CA$8.70 Million | +5.01% |
| 2019 | CA$8.28 Million | +25.30% |
| 2018 | CA$6.61 Million | -3.65% |
| 2017 | CA$6.86 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 4th, 2026 the market cap of Big Pharma Split Corp Class A was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $14.75 Million USD |
| MoneyControl | $14.75 Million USD |
| MarketWatch | $14.75 Million USD |
| marketcap.company | $14.75 Million USD |
| Reuters | $14.75 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Big Pharma Split Corp Class A
Big Pharma Split Corp is a closed ended equity mutual fund launched and managed by Harvest Portfolios Group Inc. It invests in the public equity markets across United States. The fund primarily invests in the Pharmaceutical sector. Big Pharma Split Corp was formed on September 15, 2017 and is domiciled in Canada.